Evidence map›Paper›PMID 30134925›Full record

ReviewGlobalization and health2018

Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin.

Simón Barquera, Dean Schillinger, Carlos A Aguilar-Salinas, Marc Schenker, Luis A Rodríguez, Cesar Hernández-Alcaraz, Jaime Sepúlveda-Amor, Mexico-California Diabetes collaborative group

Abstract readReview
In one paragraph

Review in Globalization and health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Simón BarqueraInstituto Nacional de Salud Pública, Avenida Universidad 655, Santa María Ahuacatitlán, 62100, Cuernavaca, Mexico.
Dean SchillingerUCSF Division of General Internal Medicine at San Francisco General Hospital, 1545 Divisadero St., First and Second Floors, San Francisco, CA, 94115, USA.
Carlos A Aguilar-SalinasInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Avenida Vasco de Quiroga No.15, Colonia Belisario Domínguez Sección XVI, Delegación Tlalpan C.P, 14080, Ciudad de Mexico, Mexico.
Marc SchenkerUC Davis School of Medicine, Department of Public Health Sciences, University of California Davis Medical Sciences 1-C, One Shields Avenue, Davis, CA, 95616, USA.
Luis A RodríguezUCSF School of Medicine, Department of Epidemiology & Biostatistics, 550 16th St, San Francisco, CA, 94158, USA.
Cesar Hernández-AlcarazInstituto Nacional de Salud Pública, Avenida Universidad 655, Santa María Ahuacatitlán, 62100, Cuernavaca, Mexico.
Jaime Sepúlveda-AmorInstituto Nacional de Salud Pública, Avenida Universidad 655, Santa María Ahuacatitlán, 62100, Cuernavaca, Mexico. Jaime.Sepulveda@ucsf.edu.
Mexico-California Diabetes collaborative group

Funding

UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Enhancing Mexican Capacity for CVD Policy ResearchR03TW009061 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BIBBINS-DOMINGO, KIRSTEN, FERNANDEZ, ALICIA · 2013 to 2015
$156k
Race/Ethnic Specific Association Between Anthropometry, Liver Fat and Incident Type 2 Diabetes: Evidence from The Multi-Ethnic Study of AtherosclerosisF31DK115029 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RODRIGUEZ, LUIS A · 2018 to 2020
$102k
FIC NIH HHS R03 TW009061FIC NIH HHS R03TW009061NIDDK NIH HHS 2 P30-DK092924NIDDK NIH HHS F31 DK115029NIDDK NIH HHS F31-DK115029NIDDK NIH HHS P30 DK092924NIDDK NIH HHS P30 DK098722
6 · The paper itself

Abstract

backgroundType 2 Diabetes (T2D) is now a massive epidemic in both California and Mexico, with serious consequences for social and economic well-being. A large proportion of these populations share common ethnic backgrounds. Yet diverse environmental and social conditions across regions create unique opportunities to explore the ways that T2D risk, incidence, management and outcomes manifest. MAIN TEXT: An action-oriented research consortium headed up by the University of California and Universidad Nacional Autónoma de Mexico was constituted to set priorities for bi-national translational research, in an attempt to implement and evaluate clinical, public health and policy actions to decrease the burden of T2D for people of Mexican origin. In this paper, we describe the epidemiology of T2D in Mexico and California, review current efforts to combat the epidemic, highlight gaps in knowledge and identify urgent areas of opportunity for collaboration. The group has developed a common research agenda and funding has been obtained to evaluate biological samples from the 2016 Mexican Health Survey, collaborate in a telemedicine-based retinopathy project, implement interventions in food banks, promote a communications campaign, and design a large-scale diabetes prevention effectiveness trial.

conclusionsT2D has caused a state of emergency in Mexico and is a major health problem among Mexican populations on both sides of the border. Understanding the commonalities and differences between California and Mexico for those of Mexican origin with respect to T2D, when combined with a sharing of knowledge and advances, can produce a bi-national translational research agenda to inform relevant policy and practice. Amidst economic and political uncertainty and limited healthcare budgets, this collaboration can contribute to the development of scientific evidence to inform policies and interventions. This may provide a promising collaborative model that could be expanded to other health conditions and regions of the world.

Indexed as

International CooperationCaliforniaDiabetes Mellitus, Type 2Health SurveysHumansIncidenceMexican AmericansMexicoRiskTranslational Research, BiomedicalUnited StatesCalifornia, Mexico, Diabetes, Prevention, Global Health, Translational Research, Health Policy

Identifiers

PMID30134925
PMCPMC6104005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.